Malaria Diagnostics Market Analysis & Forecast: 2026-2033
The global malaria diagnostics market size is expected to reach around USD 952.6 Mn in 2026 and is projected to grow at a CAGR of 5.5% during the forecast period (2026-2033), totaling USD 1,386 Mn by 2033.
The global malaria diagnostics market is expected to register steady growth during the forecast period. This is attributable to rising prevalence of malaria in endemic regions, increasing government and international initiatives for malaria control, and growing adoption of rapid diagnostic tests (RDTs) and advanced molecular diagnostic technologies.
Malaria is a parasitic disease caused by Plasmodium species and transmitted to humans through the bites of infected female Anopheles mosquitoes. It is very common in tropical and subtropical areas, especially in sub-Saharan Africa, South Asia, and Southeast Asia. Early diagnosis and timely treatment with appropriate antimalarial drugs significantly reduce the risk of severe complications and mortality.
Malaria parasites can be identified by examining a patient’s blood sample under a microscope, mostly by using thick and thin blood smears prepared on microscope slides. Several diagnostic methods are available in the market, including microscopy, rapid diagnostic tests (RDTs), and molecular diagnostic techniques such as polymerase chain reaction (PCR).
|
Current Event |
Description and its Impact |
|
WHO Global Malaria Eradication Initiatives and Funding Changes |
|
|
Technological Advancement in Point-of-Care Diagnostics |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Based on technology, rapid diagnostic tests segment is expected to account for a market revenue share of about 60% in 2026. This is attributable to their ability to provide quick, reliable, and cost-effective malaria detection, particularly in resource-limited and remote settings where access to advanced laboratory infrastructure is limited.
Rapid diagnostic tests (RDTs) allow healthcare professionals to detect malaria parasites within 15–20 minutes using a small blood sample. They eliminate the need for complex equipment and skilled laboratory personnel. Their ease of use, low cost, portability, quick results, and minimal training requirements make them highly suitable for point-of-care testing in rural clinics, community health programs, and emergency settings.
To learn more about this report, Download Free Sample
Africa is expected to lead the global malaria diagnostics market with a share of 80% in 2026. This is attributable to high burden of malaria, increasing government initiatives to counter malaria burden, and rising adoption of advanced malaria diagnostic technologies like rapid diagnostic tests (RDTs) in community clinics and rural health posts.
Africa remains at the forefront when it comes to malaria cases and deaths. For instance, according to the World Health Organization, African region was home to 95% of malaria cases and 95% of malaria deaths. This, in turn, is providing a strong impetus for the growth of African malaria diagnostic market.
The African Union and member states are actively scaling up malaria control measures. These include distributing next‑generation insecticide‑treated bed nets and delivering seasonal malaria chemoprevention (SMC) to tens of millions of children under five. These efforts help drive demand for accurate and widespread diagnostic testing to detect infection early and ensure proper care.
Asia Pacific malaria diagnostics market is poised to record a CAGR of around 6.0% during the forecast period. This is mostly due to increasing adoption of advanced malaria diagnostic technologies and strengthening healthcare infrastructure. Investments in molecular diagnostics, rapid diagnostic tests (RDTs), and mobile health initiatives to support malaria control and elimination programs are also supporting market growth in the region.
Nations such as India, Indonesia, and Myanmar are focusing on enhanced malaria surveillance, targeted elimination campaigns, and improvements in community-level health services. This, in turn, is increasing the demand for diagnostic tools capable of detecting both high and low parasite levels. As a result, the malaria diagnostics market outlook in Asia Pacific appears promising.
Nigeria is becoming one of the fastest-growing malaria diagnostics markets globally. This is attributable to rising incidence of malaria and increasing government initiatives for early detection and treatment. Similarly, growing awareness among the population about preventive healthcare measures is supporting market expansion.
Expansion of local manufacturing to improve supply security is boosting Nigeria malaria diagnostics market dynamics. Recent developments show a move toward producing malaria test kits locally. For example, Codix Bio Ltd, in partnership with SD Biosensor, is building a facility near Lagos with an annual capacity of over 147 million kits to address funding gaps from external donors and meet domestic demand.
The malaria diagnostics market in India is expected to grow steadily during the forecast period, owing to by rapid technological adoption, government elimination goals, and evolving public‐health strategies. Under its National Strategic Plan, India is pushing toward zero malaria by 2027. This is prompting broad deployment of malaria diagnostics, especially rapid tests and case reporting tools in endemic regions.
India is increasingly using molecular diagnostic technologies like PCR, which provide higher sensitivity and specificity, especially for low parasitemia and asymptomatic infections. The use of new digital health tools (AI surveillance apps) and mobile reporting platforms is improving outbreak tracking and case management across states.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 952.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.5% | 2033 Value Projection: | USD 1,386 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Nikon Corporation, Bio-Rad Laboratories Inc., Siemens Healthineers, BioMérieux, Abbott Laboratories, Access Bio, Thermo Fisher Scientific Inc., Meril Life Sciences Pvt Ltd., and Premier Medical Corporation Pvt Ltd., among others |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The incidence of malaria remains high, especially in sub‑Saharan Africa, South Asia, and Latin America. According to the World Health Organization (WHO) World Malaria Report 2025, there were an estimated 282 million malaria cases and 610,000 malaria deaths globally in 2024. The WHO African Region accounted for approximately 265 million cases, representing the vast majority of the global malaria burden. This high prevalence is expected to drive demand for accurate and timely malaria diagnostic solutions, thereby supporting growth in the malaria diagnostics market.
Growing demand for advanced diagnostic tools in malaria‑endemic regions is expected to boost the global malaria diagnostics market. Leading malaria diagnostics companies and research institutions are developing novel solutions with improved features. For example, in 2025, researchers developed and evaluated a low‑cost, near point-of-care molecular test that can detect low-level and asymptomatic malaria infections, helping improve detection, treatment, and public health surveillance.
The global malaria diagnostics market is witnessing the introduction of novel solutions amid growing emphasis on early detection and the need for accurate diagnosis due to antimalarial drug resistance. These innovations include rapid diagnostic tests (RDTs), molecular diagnostics, and point-of-care (POC) solutions. Improvements in speed, affordability, and ease of use are making RDTs a cornerstone of malaria diagnosis, especially in low-resource settings.
Molecular techniques such as PCR and Loop-Mediated Isothermal Amplification (LAMP) offer higher sensitivity and specificity, detect low parasitemia, and improve species differentiation, aiding treatment decisions and surveillance. This makes them essential for treatment decisions and surveillance. Similarly, POC solutions enable testing outside traditional laboratories, expanding access to timely malaria diagnosis.
Rising adoption of point-of-care testing (POCT), especially rapid diagnostic tests (RDTs), is a key growth-shaping trend in the malaria diagnostics market. RDTs are increasingly favored for their simplicity, quick results, and minimal infrastructure requirements, making them particularly useful in locations lacking laboratory facilities. This shift towards decentralized and remote diagnostics is expected to support expansion of the malaria diagnostics market in the coming years.
Development of AI‑assisted diagnostics, digital microscopy, cloud‑connected reporting tools, and research into non‑invasive testing methods, such as saliva‑ and urine‑based approaches, is gaining traction. These innovations are expected to play an important role in driving the growth of the global malaria diagnostics market throughout the forecast period.
Government initiatives to prevent malaria are expected to offer lucrative growth opportunities for players in the global malaria diagnostics market. National governments, the World Health Organization (WHO), the Global Fund, and NGOs are increasing funding to support mass screening, surveillance programs, and expanded access to diagnostic tools, especially in endemic countries.
For instance, World Health Organization’s Global Malaria Programme (GMP) coordinates the organization’s global efforts to control and eliminate malaria. Moreover, the Nigerian government, through its National Malaria Elimination Programme (NMEP), has scaled up the distribution of mosquito nets, improved access to effective drug therapies, and expanded vector control strategies.
Increasing public awareness about malaria is expected to support growth in the global malaria diagnostics market. Initiatives like World Malaria Day, observed annually on 25 April by the World Health Organization, highlight global efforts to combat malaria and reinforce the importance of early detection and treatment.
Public health campaigns and educational programs are helping communities understand that timely diagnosis can significantly reduce mortality and disease transmission. In regions with accessible healthcare infrastructure, this growing awareness is driving demand for malaria diagnostic tests, contributing to steady market expansion.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
